Sinovac Biotech Ltd (SVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 115,453 | 52,326 | 15,391 | 81,111 | 64,343 |
| Cost of Goods | 14,113 | 7,561 | 1,981 | 12,251 | 10,347 |
| Gross Profit | 101,340 | 44,765 | 13,410 | 68,860 | 53,996 |
| Operating Expenses | 73,691 | 45,526 | 23,230 | 40,308 | 40,577 |
| Operating Income | 27,762 | -200 | -8,839 | 28,803 | 13,766 |
| Interest Expense | 531 | 373 | 221 | 159 | 147 |
| Other Income | -417 | 472 | 598 | 890 | 937 |
| Pre-tax Income | 26,814 | -101 | -8,462 | 29,534 | 14,556 |
| Income Tax | 5,662 | 1,170 | -1,059 | -3,286 | 2,858 |
| Net Income Continuous | 21,152 | -1,271 | -7,403 | 32,820 | 11,698 |
| Minority Interests | 9,991 | 2,489 | -1,541 | 9,625 | 3,904 |
| Net Income | $11,161 | $-3,760 | $-5,862 | $23,195 | $7,794 |
| EPS Basic Total Ops | 0.10 | -0.05 | -0.07 | 0.24 | 0.06 |
| EPS Basic Continuous Ops | 0.21 | -0.01 | -0.07 | 0.35 | 0.12 |
| EPS Diluted Total Ops | 0.10 | -0.05 | -0.07 | 0.23 | 0.06 |
| EPS Diluted Continuous Ops | 0.19 | -0.01 | -0.07 | 0.28 | 0.12 |
| EBITDA(a) | $28,041 | $1,357 | $-8,072 | $29,949 | $14,980 |